Joseph Rostock - Veradigm Sr CTO

MDRX Stock  USD 4.50  0.55  10.89%   

Insider

Joseph Rostock is Sr CTO of Veradigm
Age 61
Address 222 Merchandise Mart Plaza, Chicago, IL, United States, 60654
Phone800 334 8534
Webhttps://veradigm.com

Veradigm Management Efficiency

Return On Tangible Assets is likely to drop to -0.1 in 2025. Return On Capital Employed is likely to drop to -0.02 in 2025. At this time, Veradigm's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 1.3 B in 2025, whereas Total Current Assets are likely to drop slightly above 479.5 M in 2025. Veradigm's management efficiency ratios could be used to measure how well Veradigm manages its routine affairs as well as how well it operates its assets and liabilities.
Veradigm currently holds 219.44 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Veradigm has a current ratio of 3.17, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Veradigm's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Joacim LindoffArjo AB
50
Pardeep MBAWashTec AG
N/A
Gerald StrohmaierValneva SE
N/A
Brian LevinkindWashTec AG
57
Sara BondWashTec AG
N/A
Stanley JDPanamera Holdings
75
Jonas CederhageArjo AB
52
Engineer CangioliELEn SpA
58
Benjamin JenningsPanamera Holdings
58
Fabio RoppoliSafilo Group SpA
N/A
Dipal PatelValneva SE
N/A
BSc BScWashTec AG
48
JuanCarlos MDValneva SE
52
Franck MBAValneva SE
56
Maria NilssonArjo AB
N/A
Ingrid CarlssonArjo AB
47
Eva FongWashTec AG
N/A
Daniel FldtArjo AB
47
Christian StentoftArjo AB
39
Yuehui XieLifeTech Scientific
54
Joshua DrummValneva SE
N/A
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Allscripts Hlthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 8000 people. Veradigm (MDRX) is traded on NASDAQ Exchange in USA and employs 2,450 people. Veradigm is listed under Health Care Technology category by Fama And French industry classification.

Management Performance

Veradigm Leadership Team

Elected by the shareholders, the Veradigm's board of directors comprises two types of representatives: Veradigm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Veradigm. The board's role is to monitor Veradigm's management team and ensure that shareholders' interests are well served. Veradigm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Veradigm's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elliot Bryant, Senior Unit
Tehsin Syed, Chief Officer
Richard Poulton, Pres and CFO
Lisa CPC, Senior Officer
John Mayr, Senior Organization
Gregory Garrison, Independent Director
Rebecca Whaley, VP Marketing
MD MBA, Interim Director
John Sage, Senior Sales
Joseph Rostock, Sr CTO
Richard Elmore, Senior Strategy
Tejal JD, General Affairs
Paul Lewis, Sr Mang
Donald Trigg, Chief Director
Dave Dornstreich, VP Division
Leland Westerfield, Interim Officer
Thomas Langan, President Officer
Tejal Vakharia, General Affairs
Stella Chang, Executive Division
Tally Baker, Chief Officer
Jenny Gelinas, Vice Relations
Leah Jones, Chief Officer
Alan Fowles, President International

Veradigm Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Veradigm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Veradigm Stock Analysis

When running Veradigm's price analysis, check to measure Veradigm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veradigm is operating at the current time. Most of Veradigm's value examination focuses on studying past and present price action to predict the probability of Veradigm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veradigm's price. Additionally, you may evaluate how the addition of Veradigm to your portfolios can decrease your overall portfolio volatility.